← Evidence map

ArticlePharmacoEconomics2026

NICE Appraisals of Relugolix-CT and Linzagolix for Endometriosis Symptom Management: Commentary on Clinical and Economic Uncertainties.

Venetia Qendri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

NICE Appraisals of Relugolix-CT and Linzagolix for Endometriosis Symptom Management: Commentary on Clinical and Economic Uncertainties. | OpenQuestion